These techniques made it possible to support the research theory that an overexpression of NANOG and other markers of pluripotency and stemness in meningiomas, such as SOX2 and OCT4, could be exploited to target potentially pluripotent "stem cell-like" cells [12]. Here, SOX2 is linked to meningioma.